ARTICLE | Clinical News
iCo-007: Completed Phase II enrollment
June 24, 2013 7:00 AM UTC
iCo said investigators completed enrollment in the U.S. Phase II iDEAL trial to evaluate intravitreal injections of 350 and 700 µg iCo-007 alone and in combination with laser photocoagulation or ranib...